Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
09 janv. 2025 05h00 HE
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08 janv. 2025 21h00 HE
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08 janv. 2025 10h00 HE
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.